Your browser doesn't support javascript.
loading
Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Kosiborod, Mikhail; Cavender, Matthew A; Fu, Alex Z; Wilding, John P; Khunti, Kamlesh; Holl, Reinhard W; Norhammar, Anna; Birkeland, Kåre I; Jørgensen, Marit Eika; Thuresson, Marcus; Arya, Niki; Bodegård, Johan; Hammar, Niklas; Fenici, Peter.
Afiliação
  • Kosiborod M; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Cavender MA; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Fu AZ; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Wilding JP; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Khunti K; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Holl RW; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Norhammar A; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Birkeland KI; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Jørgensen ME; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Thuresson M; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Arya N; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Bodegård J; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Hammar N; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
  • Fenici P; From Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City (M.K.); University of North Carolina, Chapel Hill (M.A.C.); Georgetown University Medical Center, Washington, DC (A.Z.F.); University of Liverpool, United Kingdom (J.P.W.); University of Leicester, United Kingdom (K
Circulation ; 136(3): 249-259, 2017 Jul 18.
Article em En | MEDLINE | ID: mdl-28522450

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte / Europa Idioma: En Revista: Circulation Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte / Europa Idioma: En Revista: Circulation Ano de publicação: 2017 Tipo de documento: Article